Literature DB >> 26390870

Creation of small gelatin particles by pumping method for transarterial chemoembolization of hepatocellular carcinoma: analysis of particle size and reproducibility.

Toshiyuki Irie1.   

Abstract

PURPOSE: Spherical porous gelatin particles (Gelpart(®), Nippon Kayaku, Tokyo) were crushed by a pumping method to create small gelatin particles for transarterial chemoembolization of hepatocellular carcinoma. The aim of this study was to analyze crushed particle size.
MATERIALS AND METHODS: To minimize the size of crushed particles, we used the pumping method using two 2.5-mL syringes connected by a 3-way stopcock. Sixteen samples created by 3 operators were examined. The crushed particles were stained with hematoxylin-eosin, images magnified by a microscope were captured using a digital camera, and the maximum length of each particle was measured. The differences in particle size within the same operator and among the 3 operators were examined by an ANOVA test.
RESULTS: The particle sizes created by each operator were 139.0 ± 58.8, 201.1 ± 90.9, and 158.4 ± 72.0 µm, respectively. There was a statistically significant difference in particle size among the 3 operators (p < 0.01). With one operator, there was no statistically significant difference in the particle size among the 4 samples (p = 0.93). With 2 operators, there were statistically significant differences among 5, or 7 samples, respectively (p < 0.01).
CONCLUSION: Small gelatin particles can be created with Gelpart(®) by the pumping method, but mean particle size was different among samples and not reproducible.

Entities:  

Keywords:  Gelatin particle; Hepatocellular carcinoma; Pumping method; TACE

Mesh:

Substances:

Year:  2015        PMID: 26390870     DOI: 10.1007/s11604-015-0480-8

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  8 in total

1.  [Rapid production of gelatin sponge particles for transcatheter arterial embolization: pumping method].

Authors:  H Mori; Y Saida; Y Watanabe; T Irie; Y Itai
Journal:  Nihon Igaku Hoshasen Gakkai Zasshi       Date:  2000-10

2.  The size of gelatin sponge particles: differences with preparation method.

Authors:  Tetsuya Katsumori; Toshiyuki Kasahara
Journal:  Cardiovasc Intervent Radiol       Date:  2006 Nov-Dec       Impact factor: 2.740

3.  Diameter of main tumor feeding artery of a hepatocellular carcinoma: Measurement at the entry site into the nodule.

Authors:  Toshiyuki Irie; Masashi Kuramochi; Nobuyuki Takahashi
Journal:  Hepatol Res       Date:  2015-06-06       Impact factor: 4.288

4.  Ultraselective transcatheter arterial chemoembolization with a 2-f tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil.

Authors:  Shiro Miyayama; Osamu Matsui; Masashi Yamashiro; Yasuji Ryu; Keiko Kaito; Kumi Ozaki; Taro Takeda; Norihide Yoneda; Kazuo Notsumata; Daisyu Toya; Nobuyoshi Tanaka; Takeshi Mitsui
Journal:  J Vasc Interv Radiol       Date:  2007-03       Impact factor: 3.464

5.  Porous gelatin particles for uterine artery embolization: an experimental study of intra-arterial distribution, uterine necrosis, and inflammation in a porcine model.

Authors:  Miyuki Sone; Keigo Osuga; Kohki Shimazu; Hiroki Higashihara; Tetsuro Nakazawa; Kenichi Kato; Makiko Tomabechi; Shigeru Ehara; Hironobu Nakamura; Eiichi Morii; Katsuyuki Aozasa
Journal:  Cardiovasc Intervent Radiol       Date:  2010-07-15       Impact factor: 2.740

6.  Bland embolization in patients with unresectable hepatocellular carcinoma using precise, tightly size-calibrated, anti-inflammatory microparticles: first clinical experience and one-year follow-up.

Authors:  Guido Bonomo; Vittorio Pedicini; Lorenzo Monfardini; Paolo Della Vigna; Dario Poretti; Gianluigi Orgera; Franco Orsi
Journal:  Cardiovasc Intervent Radiol       Date:  2009-12-03       Impact factor: 2.740

7.  Guidelines on the use of gelatin sponge particles in embolotherapy.

Authors:  Shiro Miyayama; Koichiro Yamakado; Hiroshi Anai; Daisuke Abo; Tetsuya Minami; Haruyuki Takaki; Taishi Kodama; Takashi Yamanaka; Hideyuki Nishiofuku; Kengo Morimoto; Takeshi Soyama; Yu Hasegawa; Koichi Nakamura; Tomoaki Yamanishi; Morio Sato; Yasuo Nakajima
Journal:  Jpn J Radiol       Date:  2014-02-08       Impact factor: 2.374

8.  Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma.

Authors:  Mary A Maluccio; Anne M Covey; Leah Ben Porat; Joanna Schubert; Lynn A Brody; Constantinos T Sofocleous; George I Getrajdman; William Jarnagin; Ronald Dematteo; Leslie H Blumgart; Yuman Fong; Karen T Brown
Journal:  J Vasc Interv Radiol       Date:  2008-04-10       Impact factor: 3.464

  8 in total
  2 in total

1.  Balloon-Occluded Trans-Arterial Chemoembolization Technique with Alternate Infusion of Cisplatin and Gelatin Slurry for Small Hepatocellular Carcinoma Nodules Adjacent to the Glisson Sheath.

Authors:  Toshiyuki Irie; Nobuyuki Takahashi; Toshiro Kamoshida
Journal:  Biomed Res Int       Date:  2019-05-09       Impact factor: 3.411

2.  Balloon-Occluded Trans-Arterial Chemo-Embolization Technique with Repeated Alternate Infusion of Cisplatin Solution and Sparse Gelatin Slurry (RAIB-TACE) for Large Hepatocellular Carcinoma Nodules More than 7 cm in Diameter.

Authors:  Toshiyuki Irie; Nobuyuki Takahashi; Toshiro Kamoshida; Junya Kashimura; Hiroyuki Ariga
Journal:  Biomed Res Int       Date:  2020-01-19       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.